RecruitingNCT06222164
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
Sponsor
Invivoscribe, Inc.
Enrollment
2,000 participants
Start Date
Mar 30, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
- Donor Age ≥ 18 years
Exclusion Criteria2
- Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
- The specimens/samples have previously been enrolled in a clinical study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06222164
Related Trials
Autologous Testicular Tissue Transplantation
NCT054140451 location
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
NCT054775636 locations
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
NCT046409871 location
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
NCT072576401 location
HEME Home Transfusion Program
NCT064872472 locations